[Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008875:Middle Aged; D011412:Propanolamines / Q000494:pharmacology*; D011674:Pulse / Q000187:drug effects; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D007545:Isoproterenol
Hämodynamische Wirkungen der neuen beta-Rezeptoren blockierenden Substanz Talinolol (Cordanum, 02-115) am Menschen